[p53 mutations and human solid tumors]. 1993

C Theillet
CNRS, URA 1191, Génétique Moléculaire, Université Montpellier, France.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016158 Genes, p53 Tumor suppressor genes located on the short arm of human chromosome 17 and coding for the phosphoprotein p53. Genes, TP53,TP53 Genes,p53 Genes,Gene, TP53,Gene, p53,TP53 Gene,p53 Gene

Related Publications

C Theillet
April 1992, Cancer research,
C Theillet
November 1991, Cancer research,
C Theillet
July 1995, Molecular carcinogenesis,
C Theillet
February 1994, Molecular carcinogenesis,
C Theillet
December 1998, Journal of experimental & clinical cancer research : CR,
C Theillet
September 2016, Nihon rinsho. Japanese journal of clinical medicine,
C Theillet
April 1995, The Journal of urology,
Copied contents to your clipboard!